Last reviewed · How we verify

NCT05788068

Efficacy and Neuroimaging Mechanisms of Smoking Cessation in China

Completed NA Last updated 24 August 2023
What this trial tests

NA trial testing Cognitive behavior therapy in Cigarette Smoking in 120 participants. Completed in 15 August 2023.

Timeline
1 March 2023
Primary endpoint
15 July 2023
15 August 2023

Quick facts

Lead sponsorSir Run Run Shaw Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment120
Start date1 March 2023
Primary completion15 July 2023
Estimated completion15 August 2023
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Sir Run Run Shaw Hospital

Who can join

Adults 18 to 45, any sex, with Cigarette Smoking or Psychological Interventions. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This proposed project is to assess the efficacy of CBT-based digital smoking cessation interventions in China, as well as explore its neuroimaging mechanisms.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Cognitive behavior therapy

Trials testing the same drug.

Other recruiting trials for Cigarette Smoking

Currently open trials in the same condition.

Other Sir Run Run Shaw Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05788068.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing